Copyright
        ©The Author(s) 2021.
    
    
        World J Biol Chem. Sep 27, 2021; 12(5): 87-103
Published online Sep 27, 2021. doi: 10.4331/wjbc.v12.i5.87
Published online Sep 27, 2021. doi: 10.4331/wjbc.v12.i5.87
            Table 1 Models for clinical staging in alcoholic liver disease
        
    | Model | Stratification | Bilirubin | Albumin | Prothrombin Time | Ascites | Encephalopathy | INR | Creatinine | White blood cell count | Serum urea | Age | 
| Child-Pugh[65,66] | Severe: ≥ 10 | + | + | + | + | + | |||||
| Model for End-Stage Liver disease[66] | Severe: ≥ 21 | + | + | + | |||||||
| Maddrey Discriminant Function score[66] | Severe: ≥ 32 | + | + | ||||||||
| The Glasgow Alcoholic Hepatitis Score[66] | Poor prognosis: ≥ 9 | + | + | + | + | + | |||||
| Lille Model[66,69] | ≥ 0.45: Nonresponse. < 0.45: Response | + | + | + | + | + | 
            Table 2 Current available treatments for alcoholic liver disease
        
    | Intervention | Objective | Treatment method | Treatment effects | 
| Abstinence | Stop drinking | Abstinence combined with disulfiram, naltrexone or acamprosate | Improve overall survival at all stages[70]. Acamprosate has been shown to be effective in reducing withdrawal symptoms[77] | 
| Nutritional Therapy | Replenish nutrition | 1.5 g protein and 35 to 49 kcal per kg of body weight. Supplementation with vitamins | Nutritional support showed improved hepatic encephalopathy and reduced infections in AH patients[80] | 
| Corticosteroid | Anti-inflammatory | 40 mg daily for 28 d, then 20 mg daily for 7 d, and 10 mg daily for 7 d | Short-term histological improvement has been documented, however, no improvement in long term survival[83] | 
| Pentoxifylline | Anti-cytokine | 400 mg orally three times a day for 4 wk | Reduction in the levels of cytokines and lower mortality rate[86] | 
| Infliximab | Anti-cytokine | Not confirmed. 5 mg/kg studied | Further studies required. Treatment has shown to predispose patients to higher rate of infections as well as higher likelihood of mortality[93] | 
| Liver transplantation | Surgery | Healthy ‘donor’ liver transplanted. 6 mo abstinence required | Transplantation has been shown to improve in quality of life[95,96] | 
| N-acetylcysteine | Antioxidant | Not confirmed | In animal models NAC has been shown to prevent relapse and improve injury[111]. Further research is required | 
| SAM | Antioxidant | Not confirmed | SAM therapy has improved survival and delayed the need for transplants however other studies have not found evidence to support or refute its use[102,103] | 
| Silymarin | Herbal | Eurosil 85® 420 mg a day | Treatment with Silymarin reduced mortality and improved 4-yr overall survival in cirrhotic patients as well as improving liver function[119] | 
| Betaine | Nutrient | Not confirmed | Animal models have shown betaine supplementation can attenuate alcoholic fatty liver[106-108,120,121] | 
- Citation: Petagine L, Zariwala MG, Patel VB. Alcoholic liver disease: Current insights into cellular mechanisms. World J Biol Chem 2021; 12(5): 87-103
 - URL: https://www.wjgnet.com/1949-8454/full/v12/i5/87.htm
 - DOI: https://dx.doi.org/10.4331/wjbc.v12.i5.87
 
